New York Attorney General Eric Schneiderman says New York will get $61 million from last week’s national settlement with drug maker Merck & Co. to resolve an investigation into the marketing of the painkiller Vioxx.
A federal court has accepted Merck’s guilty plea to one misdemeanor count of violating marketing laws.
The Justice Department says the Whitehouse Station, N.J., company marketed Vioxx as a treatment for rheumatoid arthritis without federal approval for almost three years and made false settlements about its cardiovascular safety.
The drug was taken off the market in September 2004 after evidence showed it doubled the risk of heart attack and stroke.
The company says the government recognized Merck’s cooperation, and it recorded a $950 million charge in October 2010 in anticipation of the settlement agreements.
Topics New York
Was this article valuable?
Here are more articles you may enjoy.
Allstate CEO Wilson Takes on Affordability Issue During Earnings Call 
Trump’s EPA Rollbacks Will Reverberate for ‘Decades’ 
BMW Recalls Hundreds of Thousands of Cars Over Fire Risk 
What Analysts Are Saying About the 2026 P/C Insurance Market 
